2020 AAES指南:成人甲状腺疾病的明确手术治疗(概要)

2020-02-20 美国内分泌外科协会 Ann Surg. 2020 Mar;271(3):399-410.

2020年,美国内分泌外科协会(AAES)发布了成人甲状腺疾病的明确手术治疗指南,主要目的是针对甲状腺切除术提供安全、有效的建议,帮助临床医生优化甲状腺疾病的手术治疗。

中文标题:

2020 AAES指南:成人甲状腺疾病的明确手术治疗(概要)

英文标题:

Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.

发布机构:

美国内分泌外科协会

发布日期:

2020-02-20

简要介绍:

2020年,美国内分泌外科协会(AAES)发布了成人甲状腺疾病的明确手术治疗指南,主要目的是针对甲状腺切除术提供安全、有效的建议,帮助临床医生优化甲状腺疾病的手术治疗。

 

拓展指南:甲状腺相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2020 AAES指南:成人甲状腺疾病的明确手术治疗(概要))] GetToolGuiderByIdResponse(projectId=1, id=e1f011c0018e0211, title=2020 AAES指南:成人甲状腺疾病的明确手术治疗(概要), enTitle=Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults., guiderFrom=Ann Surg. 2020 Mar;271(3):399-410., authorId=null, author=, summary=2020年,美国内分泌外科协会(AAES)发布了成人甲状腺疾病的明确手术治疗指南,主要目的是针对甲状腺切除术提供安全、有效的建议,帮助临床医生优化甲状腺疾病的手术治疗。 , cover=, journalId=null, articlesId=null, associationId=402, associationName=美国内分泌外科协会, associationIntro=美国内分泌外科协会主要致力于内分泌疾病外科治疗学的发与进步,其成员具有专业的临床知识及内分泌外科学的研究兴趣,协会主要提供内分泌外科疾病(甲状腺、甲状旁腺、肾上腺、胰腺及内分泌肿瘤)的外科专业知识,旨在促进专业发展及改善病人的预后。, copyright=0, guiderPublishedTime=Thu Feb 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年,美国内分泌外科协会(AAES)发布了成人甲状腺疾病的明确手术治疗指南,主要目的是针对甲状腺切除术提供安全、有效的建议,帮助临床医生优化甲状腺疾病的手术治疗。 </P> <P> </P>拓展指南:<strong>与<font color=red>甲状腺</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=4a1a41c00186e107" title="2019 KTA实践指南:甲状腺细针穿刺活检实践指南" target=_blank>2019 KTA实践指南:甲状腺细针穿刺活检实践指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=be3701c00185324c" title="机器人甲状腺及甲状旁腺手术中神经电生理监测临床操作专家共识(2019 版)" target=_blank>机器人甲状腺及甲状旁腺手术中神经电生理监测临床操作专家共识(2019 版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b05e91c001852378" title="甲状腺功能亢进症基层诊疗指南(实践版·2019)" target=_blank>甲状腺功能亢进症基层诊疗指南(实践版·2019)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=fa1011c0018519d4" title="2020 共识声明建议:甲状腺良性结节非手术以及非放射性碘消融治疗" target=_blank>2020 共识声明建议:甲状腺良性结节非手术以及非放射性碘消融治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=73a911c0018a4299" title="甲状腺功能减退症基层诊疗指南(实践版·2019)" target=_blank>甲状腺功能减退症基层诊疗指南(实践版·2019)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%94%B2%E7%8A%B6%E8%85%BA" target=_blank>有关甲状腺更多指南</a></ul>, tagList=[TagDto(tagId=100107, tagName=成人甲状腺疾病), TagDto(tagId=3327, tagName=手术治疗)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7760, appHits=477, showAppHits=20, pcHits=3238, showPcHits=5754, likes=19, shares=20, comments=17, approvalStatus=1, publishedTime=Fri Feb 28 15:27:46 CST 2020, publishedTimeString=2020-02-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Feb 28 15:27:46 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 18:56:31 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 AAES指南:成人甲状腺疾病的明确手术治疗(概要))])
2020 AAES指南:成人甲状腺疾病的明确手术治疗(概要)
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1197570, encodeId=e3fb119e570ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Sat Feb 26 20:45:57 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063262, encodeId=83bc106326205, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 23 22:03:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004975, encodeId=fc3210049e589, content=多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/26/607a7d71746918e95b4790600e20b93a.jpg, createdBy=07842181499, createdName=Felix Tan, createdTime=Tue Aug 03 21:35:36 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004270, encodeId=b73f10042e0d6, content=已阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210718/220b30c83b8e4c129e6f0348cb3187f4/bc765baf3f99449eb7088d4e2193a812.jpg, createdBy=f1d12459715, createdName=小angel, createdTime=Sat Jul 31 20:11:42 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958995, encodeId=d04695899542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038d5424282, createdName=ms3000000795213921, createdTime=Wed Apr 21 10:03:55 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2022-02-26 ms7000000419195392

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1197570, encodeId=e3fb119e570ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Sat Feb 26 20:45:57 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063262, encodeId=83bc106326205, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 23 22:03:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004975, encodeId=fc3210049e589, content=多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/26/607a7d71746918e95b4790600e20b93a.jpg, createdBy=07842181499, createdName=Felix Tan, createdTime=Tue Aug 03 21:35:36 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004270, encodeId=b73f10042e0d6, content=已阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210718/220b30c83b8e4c129e6f0348cb3187f4/bc765baf3f99449eb7088d4e2193a812.jpg, createdBy=f1d12459715, createdName=小angel, createdTime=Sat Jul 31 20:11:42 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958995, encodeId=d04695899542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038d5424282, createdName=ms3000000795213921, createdTime=Wed Apr 21 10:03:55 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-10-23 148aef65m02暂无昵称

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1197570, encodeId=e3fb119e570ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Sat Feb 26 20:45:57 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063262, encodeId=83bc106326205, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 23 22:03:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004975, encodeId=fc3210049e589, content=多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/26/607a7d71746918e95b4790600e20b93a.jpg, createdBy=07842181499, createdName=Felix Tan, createdTime=Tue Aug 03 21:35:36 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004270, encodeId=b73f10042e0d6, content=已阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210718/220b30c83b8e4c129e6f0348cb3187f4/bc765baf3f99449eb7088d4e2193a812.jpg, createdBy=f1d12459715, createdName=小angel, createdTime=Sat Jul 31 20:11:42 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958995, encodeId=d04695899542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038d5424282, createdName=ms3000000795213921, createdTime=Wed Apr 21 10:03:55 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-08-03 Felix Tan

    多多学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1197570, encodeId=e3fb119e570ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Sat Feb 26 20:45:57 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063262, encodeId=83bc106326205, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 23 22:03:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004975, encodeId=fc3210049e589, content=多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/26/607a7d71746918e95b4790600e20b93a.jpg, createdBy=07842181499, createdName=Felix Tan, createdTime=Tue Aug 03 21:35:36 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004270, encodeId=b73f10042e0d6, content=已阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210718/220b30c83b8e4c129e6f0348cb3187f4/bc765baf3f99449eb7088d4e2193a812.jpg, createdBy=f1d12459715, createdName=小angel, createdTime=Sat Jul 31 20:11:42 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958995, encodeId=d04695899542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038d5424282, createdName=ms3000000795213921, createdTime=Wed Apr 21 10:03:55 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-07-31 小angel

    已阅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1197570, encodeId=e3fb119e570ea, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abca5684584, createdName=ms7000000419195392, createdTime=Sat Feb 26 20:45:57 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063262, encodeId=83bc106326205, content=棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 23 22:03:20 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004975, encodeId=fc3210049e589, content=多多学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/26/607a7d71746918e95b4790600e20b93a.jpg, createdBy=07842181499, createdName=Felix Tan, createdTime=Tue Aug 03 21:35:36 CST 2021, time=2021-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004270, encodeId=b73f10042e0d6, content=已阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210718/220b30c83b8e4c129e6f0348cb3187f4/bc765baf3f99449eb7088d4e2193a812.jpg, createdBy=f1d12459715, createdName=小angel, createdTime=Sat Jul 31 20:11:42 CST 2021, time=2021-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958995, encodeId=d04695899542, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=038d5424282, createdName=ms3000000795213921, createdTime=Wed Apr 21 10:03:55 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-04-21 ms3000000795213921

    学习了

    0